Whitehawk Therapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-21.4M | $-17.0M | $-31.4K | $-30.8K | $-28.7K | $-27.4K | $-27.2K | $-22.4K |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $51.3K | $69.7K | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $649.4K | $488.3K | — | — | — | — | — | — |
| Net Cash from Operating Activities | $-18.9M | $-24.5K | $-21.7K | $-16.0K | $-23.3K | $-24.5K | $-22.8K | $-19.2K |
| Investing Activities | ||||||||
| Capital Expenditures | $8.9K | $113.3K | — | — | — | — | — | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $41.1K | — | — | — | — | — | — | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $37.5M | $10.0K | $35.0K | $15.0K | $25.0K | $25.0K | $0 | $35.0K |
| Net Change in Cash | $18.7M | $-3.5M | $13.3K | $-1.0K | $1.7K | $482 | $-22.8K | $15.8K |
| Free Cash Flow | $-18.9M | $-137.8K | — | — | — | — | — | — |